Tacrolimus, Capsule, Extended Release

Product description

Tacrolimus is an immunosuppressive drug used mainly after allogeneic organ transplant to lower the risk of organrejection. It achieves this by inhibiting the production of interleukin-2, a molecule that promotes the development and proliferation of T cells, which are vital to the body's learned (or adaptive) immune response. Tacrolimus is also used in the treatment of other T cell-mediated diseases such aseczema (for which it is applied to the skin in a medicated ointment), severe refractory uveitis afterbone marrow transplants, exacerbations of minimal change disease, Kimura's disease, and the skin condition vitiligo.

Strength: 0.5mg; 1mg; 5mg.

This product is still in R&D stage.
US-ANDA is submitted in schedule.
Read more

Specifications

Categories Finished Dosage FormsCapsules; Finished Dosage Forms
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

More products from Jiangsu Hengrui Medicine Co., Ltd.

View all our products (78)

Products from other suppliers

Tacrolimus, Capsule, Extended Release

Contact information

Address

Telephone

Website

View all contact information